Atlas Trials

Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema

Clinical trial NCT01095809 · TERMINATED

Trial details

NCT number
NCT01095809
Sponsor
Hospital Clinic of Barcelona
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Uveitis
Start date
2010-04-01
Primary completion
2013-04-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.